Related Experiment Video
Updated: Jan 9, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
The Prevalence of Allergic Rhinitis in Korean Children: Nationwide Surveys in the Periods 1995-2022
Yong Ju Lee1, Hye Mi Jee2, Gitae Seo3,4
1Department of Pediatrics, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Purpose:
This study aimed to assess the current prevalence of allergic rhinitis (AR) among Korean children based on a 2022 nationwide survey and to analyze long-term trends from 1995 to 2022.
Methods:
A nationwide cross-sectional study was conducted in 2022, involving 12,558 children aged 6-13 years from randomly selected elementary and middle schools across Korea. The AR prevalence and risk factors were assessed using the modified International Study of Asthma and Allergies in Childhood Questionnaire. The data were compared with epidemiological surveys conducted in 1995, 2000, and 2010 to evaluate long-term trends.
Results:
The prevalence rates of AR symptoms during the last 12 months were 45.2%, 48.2%, and 47.8%, respectively, in children aged 6-7, 9-10, and 12-13 years, respectively. Among children aged 6-7 years, the prevalence of AR symptoms showed a long-term upward trend, rising from 29.9% in 1995 to 26.0% in 2000, 43.6% in 2010, and 45.2% in 2022 (P < 0.001). Among children aged 12-13 years, the prevalence rates also increased steadily, from 26.7% in 1995 to 31.0% in 2000, 42.7% in 2010, and 47.8% in 2022 (P < 0.001). A parental history of allergic disease and a diagnosis of atopic dermatitis were risk factors for AR symptoms during the last 12 months across all study populations from both the 2010 and 2022 surveys. Antibiotic use during infancy and male sex were significant contributors to AR development in children aged 6-7 years, whereas female sex was a significant risk factor in adolescents aged 12-13 years in 2022.
Conclusions:
The prevalence of AR among Korean children has increased over the past few decades, highlighting the importance of continuous surveillance and preventive measures. Identifying modifiable risk factors, such as early-life exposure and environmental influences, is crucial for developing targeted intervention strategies.
More Related Videos
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
06:08Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Related Concept Videos
Allergic Reactions
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: